Taiwan FDA registration 3b7566f078f535f05a1a5f376bf5740a
Abfermorphine (urine) testing system
TW: 艾博嗎啡(尿液)檢測系統
Taiwan·Risk Class 2·ABON BIOPHARM (HANGZHOU) CO., LTD·Registered Feb 27, 2007 – Feb 27, 2022CancelledRegistration details
- Analysis ID
- 3b7566f078f535f05a1a5f376bf5740a
- Customs Code
- DHA04200033801
Company information
- Manufacturer
- ABON BIOPHARM (HANGZHOU) CO., LTD
- Manufacturer Country
- China
- Authorized Representative
- Abbott Rapid Diagnostics Health Corp.
Product details
- Intended Use
- Morphine in urine is qualitatively detected using monopromologous antibody technology.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3640 嗎啡試驗系統
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Feb 27, 2007
- Expiry Date
- Feb 27, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Abfermorphine (urine) testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3b7566f078f535f05a1a5f376bf5740a and manufactured by ABON BIOPHARM (HANGZHOU) CO., LTD. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices